Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05174793 · ClinicalTrials.gov registry record · NA

Using Urine Color as a Marker of Hydration Status

A NA study of Dehydration, sponsored by San Diego State University.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT05174793: Completed NA study of Dehydration, sponsored by San Diego State University.

NCT05174793 is a NA study of Dehydration that has completed, run by San Diego State University. The registered enrollment target is 10 participants, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05174793, a NA study of Dehydration, has completed, sponsored by San Diego State University.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study was to determine if rapid changes in hydration status could be determined by urine color expressed in CIE color space

Primary Outcome

urine color expressed in CIE color space

Conditions Studied

Interventions

  • OTHER dehydration and rehydration

Study Locations (1)

California

  • San Diego State University - San Diego

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2020-03-15
Est. Completion 2020-11-15
Phase NA
San Diego State University

118 total trials

What the finished NCT05174793 record still lists

NCT05174793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 57-participant average among 20 other Dehydration trials with a reported enrollment target (82% lower).

The record links to 1 condition, with Dehydration appearing as the primary indexed condition, and to 1 intervention - of which dehydration and rehydration is the first listed.

NCT05174793 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05174793 about?

NCT05174793 is a clinical study titled "Using Urine Color as a Marker of Hydration Status". The purpose of this study was to determine if rapid changes in hydration status could be determined by urine color expressed in CIE color space

What is the current status of trial NCT05174793?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2020-03-15. Estimated completion is 2020-11-15.

What conditions does trial NCT05174793 study?

This clinical trial studies the following conditions: Dehydration.

What interventions are being tested in trial NCT05174793?

The interventions under investigation include: dehydration and rehydration (OTHER).

Who is sponsoring clinical trial NCT05174793?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05174793 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Dehydration

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05174793's enrollment target sits among peer trials

10 20th of 20 higher than 1 of 20 other Dehydration trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Dehydration trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05174793, the US trial registry maintained by the National Library of Medicine. NCT05174793 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.